Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
QUESTION: In patients with coronary artery disease (CAD), is dietary or supplemental intake of n-3 polyunsaturated fatty acids more effective than a control diet or placebo for reducing fatal and non-fatal myocardial infarction (MI) and overall mortality?
Studies in any language were identified by searching Medline, EMBASE/Excerpta Medica, Pascal BioMed, and Index Medicus from 1966 to August 1999; by searching the Cochrane Library; and by scanning bibliographies of relevant publications.
Studies were selected if they were randomised controlled trials (RCTs) that compared dietary or supplemental intake of n-3 polyunsaturated fatty acids with a control diet or placebo, reported fatal or non-fatal MI and overall mortality, and followed patients with MI or angiographically established CAD for ≥ 6 months. Studies with …
Sources of funding: University of Basel Hospitals; Byk AG; Semomed AG, Switzerland.
For correspondence: Dr H C Bucher, Institut für Klinische Epidemiologie, Kantonsspital Basel, Basel, Switzerland..